Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EntreMed and the National Cancer Institute sign letters of intent

Aug. 12, 1997

Oncormed allowed U.S. patent for BRCA1 gene

Aug. 11, 1997

Bristol-Myers Squibb acquires broad-spectrum antitumor agents

Aug. 11, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...